Family-Powered rehab app may boost ICU sleep and cut stigma
NCT ID NCT07278713
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed trial tested a family-participatory early rehab program delivered via a mobile app for 204 critically ill ICU patients. The goal was to see if it could improve sleep quality and reduce feelings of stigma compared to standard ICU care. The approach involves training family members to guide simple rehab exercises using the app.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Internet-Based, Family-Participatory Early Rehabilitation (IFPER) model
- What this could lead to
- If it works, this could offer a simple, low-cost way to improve sleep and reduce stigma for ICU patients, making recovery less distressing.
- What could go wrong
- This is a single completed trial with 204 patients, so results may not apply to all ICU settings. The intervention relies on family involvement, which may not be feasible for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
204 people
The number who actually took part.
- Started
-
Jul 2022
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Expected ICU stay of more than 48 hours * Hemodynamic stability (mean arterial pressure 65-110 mmHg with no or low-dose vasopressor support) * Stable respiratory status (PaO2/FiO2 \> 200 mmHg, SpO2 ≥ 88%) * Richmond Agitation-Sedation Scale (RASS) score ≥ -2 * Having at least one family member willing and able to participate Exclusion Criteria: * Unstable cardiovascular conditions (e.g., acute coronary syndrome, malignant arrhythmia) * Acute neurological injury with unstable intracranial pressure * Unstable fractures or spinal cord injury * Active, uncontrolled bleeding * Pre-existing severe psychiatric disorders or dementia * Inability to provide consent and no available legal surrogate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Critical illness are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fluid resuscitation optimization in surgical trauma patients (FROST)
- Tracing of real-time glu13Cose metabolism in human immune cells - intensive care unit
- Can a battery keep ventilators running during ambulance transport?
- Training may cut dangerous complications when ICU patients need breathing tubes
- Could a neck vein check replace a harder ultrasound for ICU fluid management?
- Could stepping down breathing support sooner save more lives?